Sino-Biocan (Shanghai) Biotech Ltd is an automated, modularized, closed cell production platform provider in cell & gene therapy field, providing total solution of smart tools innovation and service, devoting to be the industry leader integrating R & D, business development, techinical service, customization and production.

Sino-Biocan has developed a GMP-grade product family of fully closed, modularized, continuous cell preparation tools, as well as consumables and liquid solution, covering processes such as automated cell separation, culture, cell concentration, washing and formulation filling, cryopreservation and recovery, widely applied in cell and gene drug development, CDMO, medical and pharmaceutical stem cell preparation and application, cord blood bank management and cell storage, etc. We can also provide modular splicing of different GMP processes according to specific customer requirements for different pipelines, to realize the rapid, efficient and differentiated customization of series products of cell preparation tools.

In 2021, Sino-Biocan has completed the construction of its self-owned production base with a total area of 7600㎡in Shanghai Lingang Nanqiao Science and Technology City, which includes GMP-grade C+A consumable clean workshop, pharmaceutical grade liquid clean workshop, NMPA medical device production workshop, C+A cell & gene therapy process research and validation lab, equipment R&D lab, high clean level fully functional QC center, high level low-temperature and room-temperature warehouse, reaching production scale of 200,000 sets of consumables, 600,000 bottles of liquid reagents and 3,000 sets of equipment per year for cell & gene therapy preparation. In 2024, Sino-Biocan will expand the second-phase production base of more than 14,000㎡, intending to make it a leading production base for cell & gene therapy intelligent tools in China.

Adhering to the principle of cooperation and originality on the way of exploration, Sino-Biocan carried out project cooperation with more than ten universities, medical institutes and scientific research institutes, such as Tsinghua University, Tongji University, and constructed multi-field postdoctoral mobile stations and expert workstations. Sino-Biocan has been cooperating with Chinese Society of Blood Transfusion to explore the latest research fields of cell preparation technology and application, signed strategic cooperation agreements with dozens of middle and downstream enterprises in the industry, cooperated with more than 100 original cell and gene drug developers and CDMO companies.  At present, the company has obtained more than 50 patents and trademark certificates independently, and started international PCT application.

Sino-Biocan highly values construction of high quality standards, and has obtained ISO9001 and ISO13485 certification and submitted CE and NMPA applications.

Sticking to the concept of “innovation, development, cooperation, professionalization”, through uninterrupted intelligent and innovative technology, Sino-Biocan can meet customer’s growing demands for improving quality of all kinds of cells, cooperate with customers to improve each step of the process and become the brand leader to provide high-quality “comprehensive solution for cell preparation intelligent tools”. Be top in one market, be top in all markets.